Switzerland: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Suisse : produits médicaux et services médicaux en droit des marques

L’arrêt rendu le 29 avril 2026 par le Tribunal administratif fédéral suisse (TAF) dans l'affaire B-6574/2025 (CF & C Finance Suisse SA et Swiss DermaCosmetics SA contre Mossad Abounahi...

NG

Novagraaf Group

Switzerland And U.S. Most-Favored-Nation (MFN) Pricing – One Year In

Bär & Karrer, a Swiss law firm, provides comprehensive legal and business solutions. Contact their Zurich office for expert assistance with legal advice, business inquiries, and professional services tailored to your needs.

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences In Switzerland: Legal And Regulatory Overview

Medicinal products are products of chemical or biological origin which are intended or claimed to have a medicinal effect on the human organism, in particular in the diagnosis, prevention or treatment of diseases...

Switzerland Healthcare

BK

Bär & Karrer

EU Pharma Package: Fiscal Imports In The Supply Chain Compromise Proposal

Fiscal import involves the purchase or procurement "on paper" of medicines that have not left the territory of the European Union from an entity based outside the EU.

Switzerland Healthcare

CM

Crowell & Moring LLP

Consultation Opened On Amendments To Pharmaceutical Pricing

Switzerland Healthcare

BK

Bär & Karrer

Federal Administrative Court Draws The Line On Challenges Of Medical Tariffs

Switzerland Healthcare

BK

Bär & Karrer

Swiss & International M&A 2026: What Boards And Deal Teams Need To Know

Switzerland Commercial

LL

Loyens & Loeff

Medizinprodukte – Marktzugang und Vergütung in der obligatorischen Krankenpflegeversicherung

Switzerland Healthcare

BK

Bär & Karrer

EU-Compliance: KI-gestützte Medizinische Wearables Am Schnittpunkt Zwischen MDR, KI-Verordnung, DSGVO Und Data Act

Switzerland Privacy

FP

FABIAN PRIVACY LEGAL GmbH

Navigating EU Compliance For AI-Enabled Wearable Medical Devices: MDR, AI Act, GDPR And Data Act Interplay

Switzerland Privacy

FP

FABIAN PRIVACY LEGAL GmbH

Deal Ticker: Swiss Life Asset Managers erwirbt die GHZ Gewerbe- und Handelszentrum Schlieren AG

Switzerland Commercial

KC

Kellerhals Carrard

Bringing The EU AI Act To Life In A Multinational MedTech Organization

European Union Healthcare

FP

FABIAN PRIVACY LEGAL GmbH

Totalrevision des Zürcher Gesundheitsgesetzes – ausgewählte Neuerungen für Unternehmende

Switzerland Healthcare

VA

Vischer AG

LIR Switzerland Edition 4

Switzerland Healthcare

BK

Bär & Karrer

Suisse : produits médicaux et services médicaux en droit des marques

NG

Novagraaf Group

Your Supplier Is Using AI. Is It In Your Contract?

Switzerland Commercial

LP

Logan & Partners

Construction Delays And Arbitration: Concurrent Delay

Switzerland Litigation

Aceris Law

FinTech Laws And Regulations 2026 – Switzerland: Regulatory Developments And Legal Framework

Switzerland Commercial

BK

Bär & Karrer

Swiss Retirement Residence For Non-EU Nationals: Why Personal Ties Matter

Switzerland Employment

RC

Richmond Chambers Immigration Barristers

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

The Hague District Court Grants Injunction Against Glenmark For G-Standaard Listing Of Eltrombopag 14 Days Prior To SPC Expiry Novartis

This case concerns infringement by Glenmark on Novartis' SPC 300451 for eltrombopag (marketed as Revolade®). Novartis sought urgent relief after Glenmark included its generic "Eltrombopag Glenmark"...

Switzerland Healthcare

AO

A&O Shearman

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Am 3. September 2025 hat der Bundesrat die Botschaft zur Teilrevision des HMG zuhanden des Parlaments verabschiedet.

Switzerland Healthcare

BK

Bär & Karrer

Revision Of The Therapeutic Products Act (TPA): Increased Medication Safety And Advanced Therapy Medicinal Products

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

Switzerland Healthcare

BK

Bär & Karrer

Healthcare: Medical Devices 2025

Switzerland Healthcare

BK

Bär & Karrer

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics On Debt Financing With Hercules Capital, Inc.

Switzerland Healthcare

KC

Kellerhals Carrard

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Five Years Of Switzerland's Revised Integrity, Transparency And Discounts Framework: Current Status And Emerging Enforcement Trends

Switzerland Healthcare

BK

Bär & Karrer

Pharmaceutical Advertising 2025

Switzerland Healthcare

BK

Bär & Karrer

Panel Discussion: Supply Chain Disputes

Switzerland Litigation

BK

Bär & Karrer

Switzerland Revises Its Rules For Genetic Testing

Switzerland Healthcare

M

MME

Parallel Import Of Medicinal Products Into Switzerland

Switzerland Healthcare

VA

Vischer AG

Pharmaceutical Advertising 2025

In Switzerland, the regulation pertaining to the advertisement and promotion of medicines is spread over various statutes, ordinances and guidelines, and also includes self-regulatory codes.

Switzerland Healthcare

BK

Bär & Karrer

Panel Discussion: Supply Chain Disputes

Designed specifically for in-house counsel in the life sciences industry, the event focused on the complexities and challenges faced in managing Supply Chain Disputes, covering litigation strategies, termination risks...

Switzerland Litigation

BK

Bär & Karrer

Switzerland Revises Its Rules For Genetic Testing

These regulations include new categories as well as additional provisions for genetic testing.

Switzerland Healthcare

M

MME

Parallel Import Of Medicinal Products Into Switzerland

The import of medicinal products authorized abroad into Switzerland can have a variety of motives, the main ones being to ensure cross-border medical supplies, offset excess stocks in foreign storage facilities.

Switzerland Healthcare

VA

Vischer AG

Are You Ready For Swissdamed?

Switzerland Healthcare

M

MME

Life Sciences In 2024: Key Legal And Market Insights

What are important changes in regulation and what is to be expected from the markets in 2024? The co-heads of Kellerhals Carrard's Life Sciences Practice Group share their perspective on key developments.

Switzerland Healthcare

KC

Kellerhals Carrard

Switzerland Aims For Innovation And Digitalization In The Healthcare Sector

Consultations on the revision of the Swiss Therapeutic Products Act and the Epidemics Act are ongoing until 22 March 2024. What can Swiss healthcare stakeholders...

Switzerland Healthcare

M

MME

European Reforms And Swiss Medtech: New Legislative Amendment On 1 November 2023 About Medical Devices That Have Non-Medical Purpose

Switzerland has had to constantly adapt its legislation in this area to align with the heightened standards imposed by the EU.

Switzerland Healthcare

MM

MLL Meyerlustenberger Lachenal Froriep Ltd

Interchangeability And Incentives – Switzerland Aims At Encouraging Use Of Biosimilars And Generics

The Swiss government wants to encourage the use of biosimilars and generics with the aim of decreasing the costs of healthcare.

Switzerland Healthcare

LS

Lenz & Staehelin

SaMD - Software As A Medical Device

Switzerland Healthcare

A

Arcondis

Health Campus 2030

Switzerland Healthcare

A

Arcondis

MDR For Supply Chain 2021

Switzerland Healthcare

A

Arcondis

Merger Control Reform Could Have Big Impact, Especially For ‘National' Markets

Switzerland Anti-trust

PD

Prager Dreifuss

Software As A Medical Device – Swiss Federal Administrative Court Confirms Fertility Tracker App Is A Medical Device

European Union Healthcare

LS

Lenz & Staehelin

Medical Devices & Consumer Health Products 2022

Switzerland Healthcare

PD

Prager Dreifuss

Life Sciences 2022

Switzerland Healthcare

BK

Bär & Karrer

Vicky Walker, World-famous Surgeon, Learns About The Importance Of Confidentiality Agreements (NDAs) (Video)

LP

Logan & Partners

Germany Is Going To Specify Safety Expectations For Reimbursable Digital Health Applications

Switzerland Healthcare

BK

Bär & Karrer

Ordinance On Integrity And Transparency In The Therapeutic Products Sector Has Been Adopted

Switzerland Healthcare

BK

Bär & Karrer

Swiss Pharmaceutical Prices To Fall Further

Switzerland Healthcare

MM

MLL Meyerlustenberger Lachenal Froriep Ltd

See more

Latest Videos

See more

Vicky Walker, World-famous Surgeon, Learns About The Importance Of Confidentiality Agreements (NDAs) (Video)

LP

Logan & Partners

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More